Extract from the Register of European Patents

EP Citations: EP3236972

Cited inSearch
Type:Patent literature
Publication No.:WO2013142525  [XI]
 (ALIOS BIOPHARMA INC et al.) [X] 1,2,4,6-12,14 * page 206; example 70; compounds 73-3, 73a * * page 255 - page 261; examples 111-117 * * claims 1-15, 86, 155, 212, 224 *[I] 1,2,4,6-12,14
Type:Patent literature
Publication No.:EP2615101  [XI]
 (HIGH & NEW TECHNOLOGY RES CT HENAN ACADEMY OF SCIENCES et al.) [X] 1,2,4,6-12,14 * page 31; compounds 5-17 * * page 35; compounds 5-06, 5-07, 5-08 * * page 37; compounds 5-30, 5-31 * * page 39; compounds 5-07 * * page 40; compounds 5-17 * * claims 1,14 *[I] 1,2,4,6-12,14
Type:Non-patent literature
Publication information:[XI]   LAURENT F. BONNAC ET AL: "Structure-Activity Relationships and Design of Viral Mutagens and Application to Lethal Mutagenesis", JOURNAL OF MEDICINAL CHEMISTRY, vol. 56, no. 23, 12 December 2013 (2013-12-12), pages 9403 - 9414, XP055270188, ISSN: 0022-2623, DOI: 10.1021/jm400653j [X] 1,2,4,6-12,14 * abstract * * page 9403 * * page 9404; table 1; compounds 3, 4 *[I] 1,2,4,6-12,14
DOI: http://dx.doi.org/10.1021/jm400653j
Type:Non-patent literature
Publication information:[XPI]   OLIVER REYNARD ET AL: "Identification of a New Ribonucleoside Inhibitor of Ebola Virus Replication", VIRUSES, vol. 7, no. 12, 1 December 2015 (2015-12-01), pages 6233 - 6240, XP002783841, DOI: https://doi.org/10.3390/v7122934 [XP] 1,2,4,6-12,14 * page 6234; table 1; compound NHC *[I] 1,2,4,6-12,14
DOI: http://dx.doi.org/10.3390/v7122934
Cited inInternational search
Type:Patent literature
Publication No.:US2003087873  [XY]
 (STUYVER LIEVEN et al.) [X] 1-2, 14-18 * ; pg. 27, table 1: compound BS; para [0384], [0387] *[Y] 3, 10-13, 19-22
Type:Patent literature
Publication No.:US2014235566  [XY]
 (AMBLARD FRANCK et al.) [X] 1, 4 * ; para [0036], [0173] *[Y] 5-9, 19, 22
Type:Patent literature
Publication No.:US2004171860  [Y]
 (ZHAO HONG et al.) [Y] 5-7, 20-21 * ; para [0168] *
Type:Patent literature
Publication No.:US2014273023  [Y]
 (SALAMONE SALVATORE J et al.) [Y] 8 * ; pg. 9, Scheme 1 *
Type:Patent literature
Publication No.:WO2009143011  [Y]
 (NOVARTIS AG et al.) [Y] 10-11 * ; para [00116] *
Type:Patent literature
Publication No.:US5349947  [Y]
 (NEWHOUSE MICHAEL T et al.) [Y] 12-13 * ; col 5, para 3-4 *
Type:Patent literature
Publication No.:US2009105186  [A]
 (MATTHES ECKART et al.) [A] 1-22 * ; entire document *
Type:Patent literature
Publication No.:US5691319  [A]
 (KANEKO MASAKATSU et al.) [A] 1-22 * ; entire document *
Type:Non-patent literature
Publication information:[Y]   DATABASE Pubchem 26 October 2006 (2006-10-26), XP055455213, Database accession no. 458 [Y] 3 * , compound *
Type:Non-patent literature
Publication information:[Y]   DATABASE Pubchem 26 March 2005 (2005-03-26), XP055455220, Database accession no. 284 [Y] 9 * , compound *
Cited inby applicant
Type:Patent literature
Publication No.:US2003087873  
Type:Patent literature
Publication No.:US2014235566  
Type:Patent literature
Publication No.:US2009105186  
Type:Patent literature
Publication No.:WO2013142525  
Type:Patent literature
Publication No.:EP2615101  
Type:Patent literature
Publication No.:US6372778  
Type:Patent literature
Publication No.:US6369086  
Type:Patent literature
Publication No.:US6369087  
Type:Patent literature
Publication No.:US6372733  
Type:Non-patent literature
Publication information:  ROY ET AL.: "Pathogenesis of aerosolized Eastern equine encephalitis virus infection in guinea pigs", VIROL J, vol. 6, 2009, pages 170, XP021064278, DOI: 10.1186/1743-422X-6-170
DOI: http://dx.doi.org/10.1186/1743-422X-6-170
Type:Non-patent literature
Publication information:  STUYVER, ANTIMICROB AGENTS CHEMOTHER, vol. 47, no. 1, 2003, pages 244 - 54
Type:Non-patent literature
Publication information:  PUROHIT ET AL., J MED CHEM, vol. 55, no. 22, 2012, pages 9988 - 9997
Type:Non-patent literature
Publication information:  IVANOV ET AL., COLLECTION OF CZECHOSLOVAK CHEMICAL COMMUNICATIONS, vol. 71, no. 7, 2006, pages 1099 - 1106
Type:Non-patent literature
Publication information:  FOX ET AL., JACS, vol. 81, 1959, pages 178 - 87
Type:Non-patent literature
Publication information:  BONNAC ET AL.: "Structure-Activity Relationships and Design of Viral Mutagens and Application to Lethal Mutagenesis", J. MED CHEM, vol. 56, no. 23, 2013, pages 9403 - 9414, XP055270188, DOI: 10.1021/jm400653j
DOI: http://dx.doi.org/10.1021/jm400653j
Type:Non-patent literature
Publication information:  REYNARD ET AL.: "Identification of a New Ribonucleoside Inhibitor of Ebola Virus Replication", VIRUSES, vol. 7, no. 12, 2015, pages 6233 - 6240, XP002783841, DOI: 10.3390/v7122934
DOI: http://dx.doi.org/10.3390/v7122934
Type:Non-patent literature
Publication information:  STAHLWERMUTH: "Handbook of Pharmaceutical Salts: Properties, Selection, and Use", 2002, WILEY-VCH
Type:Non-patent literature
Publication information:  TESTAMAYER: "Hydrolysis in Drug and Prodrug Metabolism", 2006, WILEY
Type:Non-patent literature
Publication information:  "Remington's Pharmaceutical Sciences", 1989, MARCEL DEKKER, INC.
Type:Non-patent literature
Publication information:  REMINGTON: "The science and practice of pharmacy", 2000, LIPPINCOTT WILLIAMS & WILKINS
Type:Non-patent literature
Publication information:  ANSEL ET AL.: "Pharmaceutical dosage forms and drug delivery systems", 1995, WILLIAMS AND WILKINS
Type:Non-patent literature
Publication information:  LAM, ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, vol. 54, no. 8, 2010, pages 3187 - 3196